The scoring method, called the Tumor Immune Microenvironment Spatial System, or TIMES, is the first tool in the world to ...

New research reveals distinct epidemiological trends in liver cancer across Mexico, with gender and regional variations ...

Hepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new ...

Non-alcoholic fatty liver disease has no early signs. Is your liver at risk? Expert reveals these simple tests could save ...

Panelists discuss how systemic therapy plays a crucial role in embolization-eligible hepatocellular carcinoma (HCC), ...

Plectin drives hepatocellular carcinoma progression and metastasis through cytoskeletal reorganization and oncogenic signaling, making it a promising therapeutic target for overcoming therapy ...

Hepatocellular carcinoma (HCC) is the most common type of liver cancer in Switzerland and worldwide. Immunotherapy through ...

Chinese scientists and their Singaporean collaborators have developed a scoring system to predict the risk of recurrence for hepatocellular carcinoma, a serious form of liver cancer, achieving an ...